Popovic DS - Search Results

1

Zinc Levels and Diabetic Foot Ulcers: A Mini Review.

Karakousis ND, Pyrgioti EE, Georgakopoulos PN, Apergi K, Popovic DS, Papanas N. Karakousis ND, et al. Among authors: popovic ds. Int J Low Extrem Wounds. 2023 Nov 8:15347346231214209. doi: 10.1177/15347346231214209. Online ahead of print. Int J Low Extrem Wounds. 2023. PMID: 37941343 Review.

2

1 h post-load plasma glucose: Should it be re-examined as a diagnostic criterion of diabetes?

Popovic DS, Papanas N. Popovic DS, et al. Prim Care Diabetes. 2021 Jun;15(3):622. doi: 10.1016/j.pcd.2020.11.006. Epub 2020 Nov 26. Prim Care Diabetes. 2021. PMID: 33250367 No abstract available.

3

Double Diabetes: A Growing Problem Requiring Solutions.

Popovic DS, Papanas N. Popovic DS, et al. Exp Clin Endocrinol Diabetes. 2022 Apr;130(4):268-274. doi: 10.1055/a-1392-0590. Epub 2021 Feb 26. Exp Clin Endocrinol Diabetes. 2022. PMID: 33636739

4

New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?

Popovic DS, Rizzo M, Stokic E, Papanas N. Popovic DS, et al. Diabetes Ther. 2021 Jun;12(6):1605-1611. doi: 10.1007/s13300-021-01065-3. Epub 2021 May 4. Diabetes Ther. 2021. PMID: 33945140 Free PMC article.

5

One-hour Post-load Plasma Glucose Cut-off Value for Diagnosing Diabetes: Do the New Data Bring us Closer to the Answer?

Popovic DS, Papanas N. Popovic DS, et al. Exp Clin Endocrinol Diabetes. 2022 May;130(5):353. doi: 10.1055/a-1516-3850. Epub 2021 Jun 21. Exp Clin Endocrinol Diabetes. 2022. PMID: 34154021 No abstract available.

6

Beta-Catenin Signaling Pathway: Perhaps We Should Start Exploring it for Diabetic Foot Ulcer Healing?

Papanas N, Popovic DS. Papanas N, et al. Among authors: popovic ds. Int J Low Extrem Wounds. 2023 Sep;22(3):441-443. doi: 10.1177/15347346211029818. Epub 2021 Jul 2. Int J Low Extrem Wounds. 2023. PMID: 34213961

7

Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region?

Popovic DS, Stokic E, Stoian AP, Papanas N. Popovic DS, et al. Curr Vasc Pharmacol. 2022;20(4):311-312. doi: 10.2174/1570161119666210921093735. Curr Vasc Pharmacol. 2022. PMID: 34548001 No abstract available.

8

The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?

Papachristou S, Popovic DS, Papanas N. Papachristou S, et al. Among authors: popovic ds. Diabetes Metab Res Rev. 2021 Nov;37(8):e3503. doi: 10.1002/dmrr.3503. Epub 2021 Oct 15. Diabetes Metab Res Rev. 2021. PMID: 34626443

9

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review.

Popovic DS, Papanas N, Pantea Stoian A, Rizvi AA, Janez A, Rizzo M. Popovic DS, et al. Diabetes Ther. 2021 Dec;12(12):3037-3054. doi: 10.1007/s13300-021-01170-3. Epub 2021 Oct 26. Diabetes Ther. 2021. PMID: 34699021 Free PMC article. Review.

10

The Role of Fructose as a Cardiovascular Risk Factor: An Update.

Busnatu SS, Salmen T, Pana MA, Rizzo M, Stallone T, Papanas N, Popovic D, Tanasescu D, Serban D, Stoian AP. Busnatu SS, et al. Metabolites. 2022 Jan 12;12(1):67. doi: 10.3390/metabo12010067. Metabolites. 2022. PMID: 35050189 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page